Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02563 BIOSTAR PHARM-B
RT Nominal down26.000 -0.250 (-0.952%)
Disclosure of Interest

31/10/2024 16:08

{New Stock}BIOSTAR PHARM-B(02563) ends up 30% at HK$20.8

[ET Net News Agency, 31 October 2024] Shares of BIOSTAR PHARM-B (02563) closed at HK$20.8 in its first trading day, or 30% higher than its offer p ... more View All

31/10/2024 09:20

{New Stock}BIOSTAR PHARM-B opens up 34.38% at HK$21.5

[ET Net News Agency, 31 October 2024] Shares of BIOSTAR PHARM-B (02563) opened at HK$21.5 in its first trading day, or 34.4% higher than its offer ... more View All

30/10/2024 18:35  {New Stock}BIOSTAR PHARM-B ends up 30.63% on grey market

1

Remark: Real time quote last updated: 06/11/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.